To enhance its presence in regions like Europe, the Middle East, Africa and the Asia Pacific, CME Group, one of the world’s prominent derivatives marketplaces, announced a new regional leadership s
<p>Funding to support clinical advancement of SAB-142, a potential disease-modifying treatment Financing led by RA Capital Management, with participation from BVF Partners, Sessa Capital, Commod
Leave a Comment